The Parenteral Drug Association (PDA) will soon be offering improved pharmaceutical and biotechnology training and education from a new centralized facility, that will include the PDA Training and Research Institute (PDA TRI), which is currently based in Baltimore.

The new headquarters will occupy the first and second floors of the Bethesda Towers and will feature new laboratory and lecture courses to help the pharmaceutical industry understand and adopt advanced and emerging manufacturing technologies.

The association plans to add rapid microbiological tools to its microbiology lab and is planning new courses on process analytical technology (PAT) and sterile compounding. PDA also plans to establish a biopharmaceutical laboratory in the new facility.

The new laboratory will feature PDA's industry-standard, hands-on aseptic processing laboratory course, a hallmark of PDA TRI, and the facility's new cleanroom will be a state-of-the-art sterile manufacturing operation.

The current PDA headquarters will move to the new location in the third quarter of 2006. PDA TRI is expected to be established in Bethesda by the first quarter of 2007.